Select Medical Holdings Corporation reaffirmed consolidated earnings guidance for the year 2022. The company reaffirms its 2022 business outlook for revenue, which was provided on February 24, 2022. The company continues to expect consolidated revenue to be in the range of $6.25 billion to $6.40 billion for the full year of 2022.

The company is also reaffirming its previously issued three-year compound annual growth rate target for revenue only, which is expected to be in the range of 4% to 6% for 2021 through 2023. The company intends to address its business outlook and target compound annual growth rates for earnings per common share when the labor climate stabilizes.